Emergent Biosolutions Inc (N:EBS)

INK Ultra Money Free

Latest 10 SEC filings (by transaction date) for EBS within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET January 25th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Jan 17/20 Jan 16/20 Harsanyi Zsolt Direct Ownership Common Stock S - Open market or private sale -3,435 $55.00
Dec 13/19 Dec 12/19 Bailey Sue Direct Ownership Common Stock S - Open market or private sale -8,375 $53.46
Nov 19/19 Nov 18/19 Zoon Kathryn C Direct Ownership Common Stock S - Open market or private sale -1,000 $54.31
Nov 12/19 Nov 8/19 Zoon Kathryn C Direct Ownership Common Stock S - Open market or private sale -3,082 $54.15
Nov 12/19 Nov 7/19 Richard Ronald Direct Ownership Employee Stock Options (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 5,153 $18.64
Nov 12/19 Nov 7/19 Richard Ronald Direct Ownership Common Stock S - Open market or private sale -5,153 $60.00
Nov 12/19 Nov 7/19 Richard Ronald Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 5,153 $18.64
Sep 10/19 Sep 9/19 Zoon Kathryn C Direct Ownership Common Stock S - Open market or private sale -1,509 $56.12
Aug 9/19 Aug 7/19 Saran Atul Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -1,287 $44.47
Jun 3/19 Jun 3/19 Emergent BioSolutions Inc. Direct Ownership Stock Options (Right to Buy) Form 3 : Initial Statement of Beneficial Ownership of Securities    
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for EBS within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET January 25th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Jan 17/20 Jan 16/20 Harsanyi Zsolt Direct Ownership Common Stock S - Open market or private sale -3,435 $55.00
Dec 13/19 Dec 12/19 Bailey Sue Direct Ownership Common Stock S - Open market or private sale -8,375 $53.46
Nov 19/19 Nov 18/19 Zoon Kathryn C Direct Ownership Common Stock S - Open market or private sale -1,000 $54.31
Nov 12/19 Nov 8/19 Zoon Kathryn C Direct Ownership Common Stock S - Open market or private sale -3,082 $54.15
Nov 12/19 Nov 7/19 Richard Ronald Direct Ownership Employee Stock Options (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 5,153 $18.64
Nov 12/19 Nov 7/19 Richard Ronald Direct Ownership Common Stock S - Open market or private sale -5,153 $60.00
Nov 12/19 Nov 7/19 Richard Ronald Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 5,153 $18.64
Sep 10/19 Sep 9/19 Zoon Kathryn C Direct Ownership Common Stock S - Open market or private sale -1,509 $56.12
Aug 9/19 Aug 7/19 Saran Atul Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -1,287 $44.47
Jun 3/19 Jun 3/19 Emergent BioSolutions Inc. Direct Ownership Stock Options (Right to Buy) Form 3 : Initial Statement of Beneficial Ownership of Securities    
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $EBS

Competitors

Competitors with Recent Insider Filings
Horizon Therapeutics PLC (OQ:HZNP)
Arvinas (OQ:ARVN)
Merck & Co. (N:MRK)